medjournal360.com Open in urlscan Pro
2606:4700:3034::ac43:dae2  Public Scan

Form analysis
2 forms found in the DOM

GET https://medjournal360.com/

<form role="search" method="get" id="searchform" class="searchform" action="https://medjournal360.com/">
  <div class="srformd">
    <input type="text" value="" name="s" id="s" data-uw-styling-context="true" placeholder="Search">
    <input type="submit" id="searchsubmit" value="Search" data-uw-styling-context="true">
    <i class="fas fa-search" aria-hidden="true"></i>
  </div>
</form>

POST

<form id="mc4wp-form-1" class="mc4wp-form mc4wp-form-2870" method="post" data-id="2870" data-name="News Letter">
  <div class="mc4wp-form-fields">
    <div class="subsbox">
      <div class="inp">
        <input type="email" name="EMAIL" placeholder="Your email address" required="">
      </div>
      <div class="inps">
        <input type="submit" value="Sign up">
      </div>
    </div>
  </div><label style="display: none !important;">Leave this field empty if you're human: <input type="text" name="_mc4wp_honeypot" value="" tabindex="-1" autocomplete="off"></label><input type="hidden" name="_mc4wp_timestamp"
    value="1693750093"><input type="hidden" name="_mc4wp_form_id" value="2870"><input type="hidden" name="_mc4wp_form_element_id" value="mc4wp-form-1">
  <div class="mc4wp-response"></div>
</form>

Text Content

We value your privacy

We use cookies to enhance your browsing experience, serve personalized ads or
content, and analyze our traffic. By clicking "Accept All", you consent to our
use of cookies.

Customize Reject All Accept All
Customize Consent Preferences

We use cookies to help you navigate efficiently and perform certain functions.
You will find detailed information about all cookies under each consent category
below.

The cookies that are categorized as "Necessary" are stored on your browser as
they are essential for enabling the basic functionalities of the site. ... Show
more

NecessaryAlways Active

Necessary cookies are required to enable the basic features of this site, such
as providing secure log-in or adjusting your consent preferences. These cookies
do not store any personally identifiable data.

No cookies to display.

Functional

Functional cookies help perform certain functionalities like sharing the content
of the website on social media platforms, collecting feedback, and other
third-party features.

No cookies to display.

Analytics

Analytical cookies are used to understand how visitors interact with the
website. These cookies help provide information on metrics such as the number of
visitors, bounce rate, traffic source, etc.

No cookies to display.

Performance

Performance cookies are used to understand and analyze the key performance
indexes of the website which helps in delivering a better user experience for
the visitors.

No cookies to display.

Advertisement

Advertisement cookies are used to provide visitors with customized
advertisements based on the pages you visited previously and to analyze the
effectiveness of the ad campaigns.

No cookies to display.

Reject All Save My Preferences Accept All
Powered by
Skip to main contentEnable accessibility for visually impairedOpen the
accessibility menu






2a03:1b20:6:f011::6e
dgid:
enl:
npi:0
Menu
 * Home
 * Topic
     
   *   
     * Alagille Syndrome
         
       * Partial external biliary diversion shows promise in treating severe
         pruritus in pediatric liver disorders
       * Case report demonstrates durable response after treatment with
         maralixibat in ALGS
       * Delivering patient-centered care through the Mirum Access Plus program
         
     * Autoimmune
         
       * High prevalence of psoriatic arthritis found among psoriasis patients
       * Peresolimab shows promise for rheumatoid arthritis in Phase 2a trial
       * Methotrexate/prednisone combo may be effective in alopecia areata
         totalis, universalis
         
     * Cardiology
         
       * Semaglutide demonstrates significant symptom improvement and enhanced
         mobility in individuals with heart failure with preserved ejection
         fraction, obesity
       * Ultrafast-track extubation in cardiac surgery linked to lower
         postoperative complications, shorter ICU stay
       * Empagliflozin shows promise in improving insulin sensitivity in
         high-risk cardiovascular patients with dysglycaemia
         
     * Endocrinology
         
       * Empagliflozin shows promise in improving insulin sensitivity in
         high-risk cardiovascular patients with dysglycaemia
       * Telehealth is comparable to in-person visits for managing T1D
       * Health inequalities in type 1 diabetes outcomes linked to socioeconomic
         status
         
     * Gastroenterology
         
       * Single-use duodenoscope shows promise in endoscopic retrograde
         cholangiopancreatography procedures
       * Gastrointestinal symptoms may indicate primary immunodeficiency disease
       * Intravenous contrast in CT scans for undifferentiated abdominal pain
         may not be needed
         
     * Genetic and Congenital
         
       * Emerging Treatments in APDS
       * Continued use of burosumab in X-linked hypophosphatemia needed to
         sustain clinical benefit
       * First patient enrolled in pediatric clinical trial of leniolisib for
         APDS
         
     * Growth Hormone Disorders
         
       * Shortened tests can maintain diagnostic accuracy for growth hormone
         deficiency
       * High-dose recombinant human growth hormone treatment promotes growth in
         children with GHD
       * Somapacitan demonstrates sustained efficacy, patient preference in
         treating GHD in children
         
     * Hematology
         
       * Sutimlimab shows promising results in long-term relief for rare
         autoimmune hemolytic anemia
       * Study finds varying survival rates for rare bleeding disorders
       * Anemia associated with higher mortality, severe disease in hospitalized
         COVID-19 patients
         
     * Industry News
         
       * Quiz: Challenges in Conducting Rare Disease Clinical Trials
       * Ipsen to acquire Albireo accelerating growth in rare disease with
         treatments for several pediatric liver diseases
       * Amgen to buy Horizon Therapeutics
         
     * Infectious Diseases
         
       * New proposed framework assesses preventive interventions in rare
         transmissible diseases
       * Study highlights ocular manifestations in COVID-19 patients
       * Systemic corticosteroids effective and safe for treating severe
         community-acquired pneumonia
         
     * Inherited Retinal Diseases
         
       * Adaptive optics holds promise for early detection, monitoring of
         inherited retinal diseases
       * Emerging challenges and opportunities in genetic counseling for
         inherited retinal diseases
       * New research sheds light on prevalence of inherited retinal diseases in
         the US
         
     * Internal Medicine
         
       * Psilocybin shows potential as promising treatment for major depressive
         disorder in Phase 2 trial
       * Steroid-ozone combo shows promise for chronic discogenic low back pain
       * Outpatient appendectomy safe, effective for uncomplicated acute
         appendicitis
         
     * Interstitial Lung Disease
         
       * Risk factors for postop acute exacerbation in patients with lung cancer
         with ILD identified
       * Quiz: Laboratory Findings in Interstitial Lung Disease
       * Pulmonary arterial hypertension in combination with ILD associated with
         worse overall prognosis
         
     * Lupus Nephritis
         
       * Phase 2 TULIP-LN Trial: Anifrolumab shows efficacy in treating lupus
         nephritis
       * High frailty prevalence and disability in women with systemic lupus
         erythematosus
       * Hydroxychloroquine non-adherence linked to increased risks of flares,
         mortality in SLE
         
     * Managed Markets
         
       * Low rates of skin cancer screening found among US volunteer
         firefighters
       * Persistent disparities, unchanged mortality rates remain issues in
         acute pulmonary embolism
       * Telehealth is comparable to in-person visits for managing T1D
         
     * Metabolic
         
       * Newborn screening for rare disease improves outcomes
       * What All Endocrinologists Should Know about Cushing disease
       * Recent-onset diabetes, weight loss increases risk for cancer
         
     * Nephrology
         
       * Insights into PH1: Understanding disease progression and risk factors
         in children
       * Elderly patients with chronic kidney disease face distinct challenges
       * Sertraline may be effective in treating uremic pruritus in patients on
         hemodialysis
         
     * Neurology
         
       * Steroid-ozone combo shows promise for chronic discogenic low back pain
       * High prevalence of frailty found among patients with chronic kidney
         disease
       * Donanemab shows promise in slowing Alzheimer’s disease progression
         
     * Oncology
         
       * Diagnostic delays due to antibiotics linked to longer time to head and
         neck cancer diagnosis
       * Timing of palliative care referral does not impact healthcare
         utilization in patients with pancreatic cancer
       * Erdafitinib demonstrates clinical benefit in patients with advanced
         solid tumors
         
     * Ophthalmology
         
       * Emerging challenges and opportunities in genetic counseling for
         inherited retinal diseases
       * Single-use topical antiseptics during surgeries lead to financial
         losses
       * Teprotumumab, tocilizumab effective in treating steroid-resistant
         thyroid eye disease
         
     * Progressive Familial Intrahepatic Cholestasis
         
       * Partial external biliary diversion shows promise in treating severe
         pruritus in pediatric liver disorders
       * Regulatory Approval and Commercialization: Developing Treatments for
         Rare Diseases
       * Ipsen to acquire Albireo accelerating growth in rare disease with
         treatments for several pediatric liver diseases
         
     * Pulmonology
         
       * Persistent disparities, unchanged mortality rates remain issues in
         acute pulmonary embolism
       * Intravascular ultrasound shows promise in thrombectomy for pulmonary
         embolism
       * Evaluating asthma endpoints in allergen immunotherapy trials may
         improve efficacy and consistency
         
     * Rheumatology
         
       * Rheumatoid arthritis increases risk of DED, corneal surface damage
       * FDA approves abaloparatide for osteoporosis in men
       * Rheumatoid arthritis incidence rate increasing worldwide
         
     * Sarcoma
         
       * Erdafitinib demonstrates clinical benefit in patients with advanced
         solid tumors
       * Study finds limited impact of biopsy type on sarcoma surgical outcomes
       * Regional hyperthermia shows promise in treating high-risk soft tissue
         sarcomas
         
     * Smith-Lemli-Opitz Syndrome
         
       * Treatment Options for Smith-Lemli-Opitz Syndrome
       * Study finds link between maternal PCOS and aneuploidy screening
         outcomes during pregnancy
       * Understanding Smith Lemli Opitz Syndrome
         
     * Thyroid Eye Disease
         
       * Teprotumumab shows links to hearing changes in patients with thyroid
         eye disease
       * Teprotumumab, tocilizumab effective in treating steroid-resistant
         thyroid eye disease
       * Tocilizumab shows promise in treating Graves’ orbitopathy
         
       
     
 * Conferences
 * Patient Warriors
 * About Us
   * About Us – Mission
   * Content Awards
   * Media Partners
   * Advisory Board
   * Industry Council
   * Business Team
   * Advertising Policy


-Advertisement-

-Advertisement-

Home Partial external biliary diversion shows promise in treating severe
pruritus in pediatric liver disorders


ALAGILLE SYNDROME




PARTIAL EXTERNAL BILIARY DIVERSION SHOWS PROMISE IN TREATING SEVERE PRURITUS IN
PEDIATRIC LIVER DISORDERS

Partial external biliary diversion (PEBD) procedure shows promise as an
effective and safe treatment option for severe pruritus in children diagnosed
with progressive familial intrahepatic cholestasis (PFIC) or Alagille syndrome
(ALGS), according to a study. The study conducted on a cohort of patients (N =
7) demonstrated significant improvements in...

Read More
By rd360stg
Case report demonstrates durable response after treatment with maralixibat in
ALGS

By rd360stg
Delivering patient-centered care through the Mirum Access Plus program

By rd360stg
Alagille Syndrome Case Study with Rubén E. Quirós-Tejeira, MD

By rd360stg
Few patients meet classical diagnostic criteria for ALGS without genetic
analysis

-Advertisement-

-Advertisement-

-Advertisement=-

By rd360stg
SPLIT’s lectureship boosts knowledge, confidence for pediatric transplant
hepatology trainees

By rd360stg
Diagnostic Challenges in Alagille Syndrome

By rd360stg
Several oral manifestations associated with congenital neonatal cholestasis

By rd360stg
Study finds predictors of survival, event-free survival in patients with ALGS
treated with maralixibat

-Advertisement-

-Advertisement-

-Advertisement=-

By rd360stg
New study evaluates efficacy of therapies for cholestatic pruritus

By rd360stg
Allucent launches decentralized clinical trial platform at 2023 World Orphan
Drug Congress

By rd360stg
Case study explores off-label use of odevixibat in ALGS

By rd360stg
Regulatory Approval and Commercialization: Developing Treatments for Rare
Diseases

-Advertisement-

Page 1 of 1312345...10...»Last »
-Advertisement-

Videos
All
Alagille Syndrome Case Study with Rubén E. Quirós-Tejeira, MD
18 Aug, 2023



Quizzes
All
Diagnostic Challenges in Alagille Syndrome
12 Jul, 2023




-Advertisement-



STAY CONNECTED! JOIN OUR NEWSLETTER


Leave this field empty if you're human:

Receive Text Notifications


CONTACT

Grandin Library Building
Six Leigh Street
Clinton, New Jersey 08809
+908-505-8899
info@ihmholdings.com


QUICK LINKS

 * Mission statement
 * Editorial Advisory Board
 * Industry Council
 * Media Partnerships
 * Content Awards
 * Topic Centers
 * Ophthalmology 360 Homepage
 * International Healthcare Education
 * International Healthcare Media, LLC


SOCIAL LINKS


 * Privacy Policy
 * Cookies Statement
 * Terms of Use

© 2023 Med Journal 360™ is a trademark of International Healthcare Media, LLC.
All rights Reserved
-Advertisement-

-Advertisement-


Please ensure Javascript is enabled for purposes of website accessibility
1
Click to subscribe to notifications

Manage Notifications

Subscribe
Your personal notification data:
Download
Clear
WonderPush fully supports european GDPR